Trade Dunelm Group PLC - DNLM
Dunelm Group PLC (DNLM), formerly known as Dunelm Mill, is a large UK-based home furnishings retailer. Headquartered in Syston, England, the Group is considered to be one of the largest homewares retailers across the country: it owns a plant for manufacturing blinds, curtains, and accessories, and operates over 170 stores, as well as an online shop. Additionally, it holds around 100 in-store Pausa coffee shops. The Dunelm share price is listed on the London Stock Exchange. It is also a part of the FTSE 250 Index. Dunelm was established by Bill and Jeany Adderley in 1979. The business’ initial goal was to trade home textiles from a market stall in Leicester. In 1984, the first official store was opened in Churchgate Leicester. As of 2018, Dunelm annual revenue was set at £1,050.1 million. Discover the latest DNLM share price on Capital.comLatest shares articles

BNP Paribas stock forecast: Q2 earnings beat estimates
BNP Paribas is a French banking group whose recent developments include a Swift ledger transaction with HSBC for Siemens and continued focus on eurozone interest rates. Explore third-party BNP price targets and technical analysis. Past performance is not a reliable indicator of future results.
14 hours ago

Boeing stock forecast: FAA investigates Miami freighter crash
Boeing is a US aerospace manufacturer whose shares remain in focus after a 767-300 freighter crash in Miami prompted an FAA investigation. Explore third-party BA price targets and technical analysis. Past performance is not a reliable indicator of future results.
15 hours ago

CaixaBank stock forecast: BPI exits Angola market
CaixaBank is a Spanish bank whose Portuguese unit, Banco BPI, agreed to sell its 33.35% stake in Banco de Fomento de Angola for €388.5m. Explore third-party CABK price targets and technical analysis. Past performance is not a reliable indicator of future results.
16 hours ago

Valneva stock forecast: EMA validates Lyme vaccine application
Valneva is a French vaccine company listed on Euronext Paris. In August, the EMA validated the marketing-authorisation application for its Lyme disease vaccine candidate with Pfizer. Explore third-party VLA price targets. Past performance is not a reliable indicator of future results.
19 hours ago